Kiyotaka Nakagawa Selected Research

Kiyotaka Nakagawa Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 07/2003
9	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 04/2011
9	Adenocarcinoma 01/2016 - 01/2004
8	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 05/2012
8	Atherosclerosis 01/2017 - 05/2009
7	Inflammation (Inflammations) 12/2023 - 06/2010
7	Body Weight (Weight, Body) 05/2019 - 12/2002
6	Obesity 01/2023 - 08/2013
4	Dementia (Dementias) 01/2018 - 10/2008
4	Diabetes Mellitus 10/2012 - 07/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2002
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 10/2002
3	Diabetes Complications 07/2012 - 08/2010
3	Infections 01/2010 - 03/2008
3	Vascular Diseases (Vascular Disease) 06/2005 - 12/2002
2	Acute Liver Failure (Fulminant Hepatic Failure) 03/2024 - 01/2020
2	Reperfusion Injury 03/2024 - 12/2002
2	Hypoxia (Hypoxemia) 01/2022 - 11/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2017
2	Alcoholic Fatty Liver 01/2022 - 01/2013
2	Colitis 11/2021 - 07/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2017 - 02/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2014 - 07/2012
2	Hyperglycemia 10/2011 - 08/2011
2	Hyperplasia 08/2010 - 06/2010
2	Weight Loss (Weight Reduction) 08/2006 - 11/2005
1	Hypercholesterolemia 01/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024
1	Atrophy 01/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Poisoning 01/2022
1	Fibrosis (Cirrhosis) 01/2022

Drug/Important Bio-Agent (IBA)

13	LipidsIBA 01/2024 - 11/2005
13	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023 - 10/2008
12	TocotrienolsIBA 10/2016 - 07/2003
8	1-Deoxynojirimycin (1 Deoxynojirimycin)IBA 05/2020 - 07/2007
8	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2018 - 01/2004
7	phosphatidylcholine hydroperoxideIBA 10/2022 - 12/2002
5	CholesterolIBA 01/2024 - 03/2004
5	Vitamin E FDA LinkGeneric 08/2015 - 11/2008
4	Messenger RNA (mRNA)IBA 01/2022 - 11/2008
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 01/2004
4	phosphatidal ethanolaminesIBA 01/2022 - 01/2016
4	Ethanolamine (Colamine)IBA 11/2021 - 02/2016
4	phosphatidylethanolamineIBA 01/2017 - 08/2010
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 01/2004
4	Triglycerides (Triacylglycerol)IBA 01/2017 - 08/2006
4	N- (1,6- dideoxyfructopyranosyl)- 1,3- dioleoyl- 2- phosphatidylethanolamineIBA 07/2012 - 12/2003
4	Proteins (Proteins, Gene)FDA Link 04/2012 - 11/2008
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2024 - 01/2013
3	PlasmalogensIBA 01/2022 - 01/2016
3	Glycerophospholipids (Phosphoglycerides)IBA 11/2021 - 02/2016
3	vinyl ether (divinyl ether)IBA 11/2021 - 01/2021
3	AntioxidantsIBA 02/2018 - 11/2009
3	CurcuminIBA 01/2018 - 05/2014
3	PolyphenolsIBA 01/2017 - 01/2013
3	ferulic acid (sodium ferulate)IBA 09/2016 - 10/2014
3	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2016 - 05/2009
3	Glycoside Hydrolases (Endoglycosidases)IBA 05/2013 - 12/2009
3	Blood Glucose (Blood Sugar)IBA 10/2012 - 07/2007
3	Tocopherols (Tocopherol)IBA 06/2010 - 02/2007
3	delta tocotrienolIBA 06/2010 - 09/2006
2	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2024 - 01/2020
2	choline plasmalogensIBA 01/2022 - 02/2017
2	Ethanol (Ethyl Alcohol)IBA 01/2022 - 01/2013
2	stearic acid (magnesium stearate)FDA LinkGeneric 01/2021 - 01/2017
2	EnzymesIBA 01/2020 - 07/2012
2	SqualeneIBA 12/2019 - 01/2019
2	GlucosidasesIBA 01/2019 - 07/2007
2	sesaminIBA 02/2018 - 09/2016
2	astaxanthine (astaxanthin)IBA 02/2018 - 06/2011
2	InterferonsIBA 01/2018 - 09/2009
2	InterleukinsIBA 01/2018 - 09/2009
2	Caspase 3 (Caspase-3)IBA 02/2016 - 08/2015
2	Antineoplastic Agents (Antineoplastics)IBA 08/2015 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 04/2012
2	Picryl Chloride (Trinitrochlorobenzene)IBA 01/2013 - 03/2012
2	Streptozocin (Streptozotocin)FDA Link 04/2012 - 10/2011
2	Glucose (Dextrose)FDA LinkGeneric 03/2012 - 08/2011
2	LuteinIBA 01/2012 - 11/2009
2	Angiogenesis InhibitorsIBA 02/2009 - 11/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2009 - 08/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2008 - 08/2008
1	trans- 1,4- Bis(2- chlorobenzaminomethyl)cyclohexane DihydrochlorideIBA 03/2024
1	Phytosterols (Plant Sterols)IBA 01/2024
1	LDL CholesterolIBA 01/2024
1	campesterolIBA 01/2024
1	Ezetimibe (Zetia)FDA Link 01/2024
1	Glucosylceramides (Glucocerebrosides)IBA 12/2023
1	OxidesIBA 12/2023
1	LipopolysaccharidesIBA 12/2023
1	Photosensitizing Agents (Photosensitizers)IBA 12/2023
1	Phosphorylcholine (Phosphocholine)IBA 01/2023
1	Linoleic Acid (Linoleate)IBA 01/2023
1	AlkaloidsIBA 01/2023
1	LysophospholipidsIBA 01/2023
1	Phospholipases (Phospholipase)IBA 01/2022

Therapy/Procedure

7	Therapeutics 09/2016 - 08/2007
4	Oral Administration 05/2019 - 11/2009
2	Caloric Restriction 01/2018 - 07/2017